{"entity":{"type":"insider","cik":"0001435618","url":"/insider/0001435618","json_url":"/insider/0001435618.json","name":"Babler Martin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":4,"first":"2019-12-19","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Babler Martin","source":"filing","n_filings":4,"first_seen":"2019-12-19","last_seen":"2025-04-03"}],"transactions":[{"id":4108632,"accession":"0001415889-25-010049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010049","line_url":"/filing/0001415889-25-010049#line-1","is_derivative":false,"issuer_cik":"0001435618","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001435618","owner_cik":"0001435618","owner_name":"Babler Martin","owner_display_name":"Babler Martin","owner_url":"/insider/0001435618","role":"Director, Officer (President, CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15650.0,"shares_display":"15,650","price_per_share":6.4366,"price_display":"6.44","price_state":"stated","total_value":100732.79,"total_display":"100,732.79","total_whole":"100,733","shares_owned_after":106454.0,"shares_owned_after_display":"106,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":2510789,"accession":"0001209191-20-039026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-039026","line_url":"/filing/0001209191-20-039026","is_derivative":false,"issuer_cik":"0001435618","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001435618","owner_cik":"0001435618","owner_name":"Babler Martin","owner_display_name":"Babler Martin","owner_url":"/insider/0001435618","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":61.859238186666666,"price_display":"61.86","price_state":"stated","total_value":927888.5728,"total_display":"927,888.57","total_whole":"927,889","shares_owned_after":3312.0,"shares_owned_after_display":"3,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider","n_lines":3},{"id":2334711,"accession":"0001209191-20-016684","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-016684","line_url":"/filing/0001209191-20-016684","is_derivative":false,"issuer_cik":"0001435618","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001435618","owner_cik":"0001435618","owner_name":"Babler Martin","owner_display_name":"Babler Martin","owner_url":"/insider/0001435618","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":63.472205026666664,"price_display":"63.47","price_state":"stated","total_value":952083.0754,"total_display":"952,083.08","total_whole":"952,083","shares_owned_after":44911.0,"shares_owned_after_display":"44,911","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider","n_lines":4},{"id":7929397,"accession":"0001209191-19-061423","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-061423","line_url":"/filing/0001209191-19-061423","is_derivative":false,"issuer_cik":"0001435618","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001435618","owner_cik":"0001435618","owner_name":"Babler Martin","owner_display_name":"Babler Martin","owner_url":"/insider/0001435618","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":53.65763411111111,"price_display":"53.66","price_state":"stated","total_value":241459.3535,"total_display":"241,459.35","total_whole":"241,459","shares_owned_after":16991.0,"shares_owned_after_display":"16,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-19","scope":"insider","n_lines":3},{"id":7929389,"accession":"0001209191-19-061423","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-061423","line_url":"/filing/0001209191-19-061423","is_derivative":false,"issuer_cik":"0001435618","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001435618","owner_cik":"0001435618","owner_name":"Babler Martin","owner_display_name":"Babler Martin","owner_url":"/insider/0001435618","role":"Director, Officer (President, CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":52.959819696,"price_display":"52.96","price_state":"stated","total_value":1323995.4924,"total_display":"1,323,995.49","total_whole":"1,323,995","shares_owned_after":61854.0,"shares_owned_after_display":"61,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-19","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847367","name":"ALUMIS INC.","url":"/issuer/0001847367","role":"Director, Officer (President, CEO and Chairman)","n_filings":1,"first_seen":"2025-04-03","last_seen":"2025-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Director, Officer (President, CEO)","n_filings":3,"first_seen":"2019-12-19","last_seen":"2020-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001435618","retrieved_at":"2026-08-22T23:38:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}